The task force that makes recommendations on cancer screening, including genetic testing, hasn't met since March 2025 but ...

The partners will stop developing BIIB122 in an all-comer population, but Denali will keep evaluating it in those with LRRK2 pathogenic variants.

Datroway gained US approval for first-line TNBC patients while Enhertu was recommended for approval in Europe as a tissue-agnostic treatment for HER2-positive tumors.

The EMA accepted Regeneron's marketing authorization application for the gene therapy and will review it under accelerated assessment.

NEW YORK – Junshi Biosciences on Thursday said China's National Medical Products Administration (NMPA) approved its checkpoint inhibitor toripalimab in combination with RemeGen's antibody-drug ...

Scribe, founded in 2018, is preparing to launch a Phase I trial of its first therapeutic candidate STX-1150, developed for hypercholesterolemia.

Foundation Medicine previously received companion diagnostic approval for its FoundationOne Liquid CDx assay alongside EMD Serono's Tepmetko.

Krystal Biotech is the furthest along in pursuing this approach and is ironing out details of a registrational trial for its ...